Clinical Trial Update: Tezepelumab in Allergic Rhinitis and Asthma Study (TEZARS) [Phase 2]

View source ↗

Summary

Phase 2 TEZARS trial evaluating tezepelumab for patients with asthma and allergic rhinitis is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Asthma

Drugs mentioned

• Tezepelumab (tezepelumab)

Snippet

Sponsor: Dr. Anne Ellis | Conditions: Asthma With Allergic Rhinitis | Phase 2 | Status: ACTIVE_NOT_RECRUITING